K. Menon

发表

Treatment regimens including the multitargeted antifolate LY231514 in human tumor xenografts.

B. Teicher, C. Shih, V. Chen, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Administration of a hemoglobin solution decreases hypoxia and increases radiation response in a rat mammary carcinoma

B. Teicher, M. Robinson, K. Menon, 1995 .

DETECTION OF AFLATOXIN PRODUCTION BY FUNGI IN SPICE SAMPLES USING HPLC AND DIRECT VISUAL CULTURAL METHODS

K. Menon, S. Nair, R. K. Bhagobaty, 2014 .

Reduced oxygenation in a rat mammary carcinoma after chemo- or radiation therapy and reoxygenation with perflubron emulsion/carbogen breathing

B. Teicher, T. Kusumoto, K. Menon, 2005, Journal of Cancer Research and Clinical Oncology.

Effect of Dose, Schedule, and Rate of Administration on Radiosensitization by a High-Concentration Perflubron Emulsion/Carbogen

B. Teicher, T. Herman, S. Holden, 1993 .

Effect of oxygen level on the enhancement of tumor response to radiation by perfluorochemical emulsions or a bovine hemoglobin preparation.

B. Teicher, T. Herman, K. Menon, 1991, International journal of radiation oncology, biology, physics.

Transforming growth factor-beta and response to anticancer therapies in human liver and gastric tumors in vitro and in vivo.

B. Teicher, P. Liu, K. Menon, 2000, International journal of oncology.

Effect of hemoglobin solution on the response of intracranial and subcutaneous 9L tumors to antitumor alkylating agents

B. Teicher, S. Holden, K. Menon, 2004, Cancer Chemotherapy and Pharmacology.

Etanidazole as a modulator of combined modality therapy in the rat 9l-gliosarcoma.

S. Sallan, B. Teicher, N. Tarbell, 1992, International journal of oncology.

Oxygenation of the rat 9L gliosarcoma and the rat 13672 mammary carcinoma with various doses of a hemoglobin solution.

B. Teicher, S. Holden, K. Menon, 1994, Artificial cells, blood substitutes, and immobilization biotechnology.

Oxygenation of tumors by a hemoglobin solution

B. Teicher, G. Schwartz, M. Robinson, 2005, Journal of Cancer Research and Clinical Oncology.

Effect of a bovine hemoglobin preparation on the response of the FSaIIC fibrosarcoma to chemotherapeutic alkylating agents

B. Teicher, T. Herman, K. Menon, 1992, Journal of Cancer Research and Clinical Oncology.

Decreased tumor oxygenation after cyclophosphamide, reoxygenation and therapeutic enhancement with a perflubron emulsion carbogen breathing.

B. Teicher, T. Kusumoto, G. Schwartz, 1993, International journal of oncology.

Reduced oxygenation in a rat mammary carcinoma post-radiation and reoxygenation with a perflubron emulsion/carbogen breathing.

B. Teicher, T. Kusumoto, M. Robinson, 1994, In vivo.

Restoration of tumor oxygenation after cytotoxic therapy by a perflubron emulsion/carbogen breathing.

B. Teicher, T. Kusumoto, M. Robinson, 1995, Artificial cells, blood substitutes, and immobilization biotechnology.

Cyclocreatine in cancer chemotherapy

B. Teicher, D. Kufe, R. Kaddurah-Daouk, 2009, Cancer Chemotherapy and Pharmacology.

Preclinical Studies in Support of Defibrotide for the Treatment of Multiple Myeloma and Other Neoplasias

K. Anderson, P. Richardson, M. Boccadoro, 2009, Clinical Cancer Research.

Production of β-glucosidase by Aspergillus terreus

S. Pushalkar, K. Menon, K. K. Rao, 1995, Current Microbiology.

Human Immunocompetent Model of Neuroendocrine Liver Metastases Recapitulates Patient-Specific Tumour Microenvironment

N. Heaton, Y. Zen, J. Ramage, 2022, Frontiers in Endocrinology.

Antiangiogenic and antitumor effects of a protein kinase Cβ inhibitor in murine Lewis lung carcinoma and human Calu-6 non-small-cell lung carcinoma xenografts

B. Teicher, M. Faul, C. Shih, 2001, Cancer Chemotherapy and Pharmacology.

Antiangiogenic and antitumor effects of a protein kinase Cbeta inhibitor in human HT-29 colon carcinoma and human CaKi1 renal cell carcinoma xenografts.

B. Teicher, M. Faul, C. Shih, 2001, Anticancer research.

Antiangiogenic and antitumor effects of a protein kinase C beta inhibitor in human hepatocellular and gastric cancer xenografts.

B. Teicher, M. Faul, C. Shih, 2001, In vivo.

In vivo studies with Interleukin‐12 alone and in combination with monocyte colony‐stimulating factor and/or fractionated radiation treatment

B. Teicher, R. Schaub, G. Ara, 1996, International journal of cancer.

Enhancement of fractionated radiation therapy by an experimental concentrated perflubron emulsion (Oxygent) in the Lewis lung carcinoma.

B. Teicher, T. Herman, K. Menon, 1992, Biomaterials, artificial cells, and immobilization biotechnology : official journal of the International Society for Artificial Cells and Immobilization Biotechnology.

Whole-body hyperthermia as an adjuvant to treatment with platinum complexes with or without etanidazole in mice bearing the Lewis lung carcinoma or the FSaLL fibrosarcoma.

B. Teicher, T. Herman, K. Menon, 1992, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

Cyclooxygenase and lipoxygenase inhibitors as modulators of cancer therapies

B. Teicher, G. Ara, S. Holden, 2004, Cancer Chemotherapy and Pharmacology.

Whole-body hyperthermia and lonidamine as adjuvant therapy to treatment with cisplatin with or without local radiation in mouse bearing the Lewis lung carcinoma.

B. Teicher, G. Ara, S. Holden, 1995, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

Stability constants of some substituted salicyclic acids and their complexes

K. Menon, D. Vartak, 1971 .

The systemic administration of lethal toxin achieves a growth delay of human melanoma and neuroblastoma xenografts: assessment of receptor contribution.

G. V. Vande Woude, B. Teicher, H. Yoshida, 2008, International journal of oncology.

Kevetrin induces apoptosis in TP53 wild-type and mutant acute myeloid leukemia cells

G. Martinelli, D. Calistri, A. Cuneo, 2020, Oncology reports.

Comparison of several antiangiogenic regimens alone and with cytotoxic therapies in the Lewis lung carcinoma

B. Teicher, G. Ara, S. Holden, 1996, Cancer Chemotherapy and Pharmacology.

Antiangiogenic and antitumor effects of a protein kinase Cbeta inhibitor in human T98G glioblastoma multiforme xenografts.

B. Teicher, M. Faul, C. Shih, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Antiangiogenic effects of a protein kinase Cβ-selective small molecule

Beverly A. Teicher, Margaret M. Faul, Michail A. Esterman, 2001, Cancer Chemotherapy and Pharmacology.

Enzymatic rationale and preclinical support for a potent protein kinase C beta inhibitor in cancer therapy.

B. Teicher, D. K. Ways, G. Ara, 1999, Advances in enzyme regulation.

Minocycline in combination with chemotherapy or radiation therapy in vitro and in vivo

B. Teicher, T. Herman, G. Schwartz, 2004, Cancer Chemotherapy and Pharmacology.

Antiangiogenic agents can increase tumor oxygenation and response to radiation therapy

C. Coleman, B. Teicher, B. Dupuis, 1994 .

Antiangiogenic and Antitumor Effects of a Protein Kinase Cβ Inhibitor in Human Breast Cancer and Ovarian Cancer Xenografts

B. Teicher, M. Faul, C. Shih, 2002, Investigational New Drugs.

Chemosensitization and radiosensitization of human lung and colon cancers by antimitotic agent, ABT-751, in athymic murine xenograft models of subcutaneous tumor growth

T. Jorgensen, H. Tian, I. Joseph, 2007, Cancer Chemotherapy and Pharmacology.

Increased tumor oxygenation and radiation sensitivity in two rat tumors by a hemoglobin-based, oxygen-carrying preparation.

B. Teicher, T. Kusumoto, M. Robinson, 1995, Artificial cells, blood substitutes, and immobilization biotechnology.

Production of beta-glucosidase by Aspergillus terreus.

S. Pushalkar, K. Menon, K. K. Rao, 1995, Current microbiology.

Increased efficacy of chemo- and radio-therapy by a hemoglobin solution in the 9L gliosarcoma.

Y. Kakeji, B. Teicher, K. Menon, 1995, In vivo.

MTA (LY231514) in combination treatment regimens using human tumor xenografts and the EMT-6 murine mammary carcinoma.

B. Teicher, J. Dempsey, K. Menon, 1999, Seminars in oncology.

Antitumor activity of cryptophycins: effect of infusion time and combination studies

B. Teicher, C. Shih, K. Menon, 2000, Cancer Chemotherapy and Pharmacology.

Preclinical Studies in Support of Defibrotide for the Treatment of Multiple Myeloma and Other Neoplasias

P. Richardson, M. Boccadoro, B. Teicher, 2009, Clinical Cancer Research.

Effect of a bovine hemoglobin preparation (SBHS) on the response of two murine solid tumors to radiation therapy or chemotherapeutic alkylating agents.

B. Teicher, T. Herman, G. Ara, 1992, Biomaterials, artificial cells, and immobilization biotechnology : official journal of the International Society for Artificial Cells and Immobilization Biotechnology.